Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.

Int J Mol Sci · 2024 · PMC10931718 · PMID 38473732

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely missed statistical significanceno p-value reported

However, the studies conducted in HFpEF barely missed statistical significance and left a consistent level of uncertainty, possibly in view of the wide heterogeneity of HFpEF phenotypes.

also in 21 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.